SK Bioscience to Acquire Future Equity in U.S. Biotech Firm Sunflower Therapeutics

SEOUL, Jul. 25 (Korea Bizwire) — SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it has agreed to invest US$2 million to acquire future shares in U.S. biotech company Sunflower Therapeutics. SK bioscience signed a simple agreement for future equity (SAFE) with Sunflower Therapeutics as part of efforts to expand [...]